A risk score based on four factors — male sex, tumor size, World Health Organization (WHO) grade, and lymphovascular invasion — predicts recurrence in patients with node-negative pancreatic ...

A new tool can help physicians determine which patients with localized pancreatic neuroendocrine tumors (PanNETs) have an ...

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring ...

The 13-point risk score can help doctors more closely monitor patients at higher risk About 10% of patients suffer a cancer recurrence, most often in their liver FRIDAY, Dec. 19, 2025 (HealthDay News) ...

The score could help better manage the follow-up care for patients who’ve had pancreatic tumors surgically removed, and whose cancers have not spread to their lymph nodes, researchers wrote Dec. 17 in ...

The new risk score could help better manage the follow-up care for patients who've had pancreatic tumors surgically removed, and whose cancers have not spread to their lymph nodes, researchers wrote ...

SAN ANTONIO – An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR ...

Greater background mucosal inflammation was associated with poorer survival outcomes in patients with ulcerative colitis who ...

Young women with breast cancer experience higher recurrence risks and often present with advanced disease due to symptomatic detection rather than standard screening. Molecular studies show young ...

Study co-author Mason Dean, a biologist at City University of Hong Kong, first noted a regular tiled pattern in micro ...